These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21502428)

  • 1. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus.
    Lewandrowski EL; Van Cott EM; Gregory K; Jang IK; Lewandrowski KB
    Am J Clin Pathol; 2011 May; 135(5):741-8. PubMed ID: 21502428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-Care Measurement of Kaolin Activated Clotting Time during Cardiopulmonary Bypass: A Single Sample Comparison between ACT Plus and i-STAT.
    Vranken NPA; Theelen AJAJ; Orbons T; Barenbrug PJC; Weerwind PW
    J Extra Corpor Technol; 2021 Mar; 53(1):57-61. PubMed ID: 33814607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin does not prolong the Sonoclot aprotinin-insensitive activated clotting time.
    Dong Y; Nuttall GA; Oliver WC; Agarwal S; Ereth MH
    J Clin Anesth; 2007 Sep; 19(6):424-8. PubMed ID: 17967670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low doses of aprotinin on clotting times activated with celite and kaolin.
    Farooqi N; De Hert S; Vlaeminck R; De Bakker A; Govaerts E; Vermeyen K
    Acta Anaesthesiol Belg; 1993; 44(3):87-92. PubMed ID: 7508668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated clotting time (ACT).
    Horton S; Augustin S
    Methods Mol Biol; 2013; 992():155-67. PubMed ID: 23546712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
    Despotis GJ; Alsoufiev AL; Spitznagel E; Goodnough LT; Lappas DG
    Ann Thorac Surg; 1996 Mar; 61(3):795-9. PubMed ID: 8619695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum nafamostat mesilate and activated coagulation time during continuous hemodiafiltration.
    Nakae H; Tajimi K
    Artif Organs; 2005 Apr; 29(4):352-4. PubMed ID: 15787634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ACT point-of-care measurements: repeatability and agreement.
    Bosch YP; Ganushchak YM; de Jong DS
    Perfusion; 2006 Jan; 21(1):27-31. PubMed ID: 16485696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celite and kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy.
    Feindt P; Seyfert UT; Volkmer I; Straub U; Gams E
    Thorac Cardiovasc Surg; 1994 Aug; 42(4):218-21. PubMed ID: 7529949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
    Wendel HP; Heller W; Gallimore MJ; Bantel H; Müller-Beissenhirtz H; Hoffmeister HE
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):41-5. PubMed ID: 7681331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of activated clotting time in children--comparison of the Celite i-STAT ACT with the Medtronic ACT II.
    Hug MI; Di Bernardo S; Berger F; Bauersfeld U; Weiss M
    Acta Anaesthesiol Scand; 2004 Feb; 48(2):211-7. PubMed ID: 14995944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of activated clotting times and standard laboratory coagulation tests in paediatric non-cardiac surgery.
    Haas T; Spielmann N; Mauch J; Schmugge M; Weiss M
    Scand J Clin Lab Invest; 2013 Feb; 73(1):29-33. PubMed ID: 23094763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of aprotinin on activated clotting time measured with different activators.
    Wang JS; Lin CY; Hung WT; Thisted RA; Karp RB
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1135-40. PubMed ID: 1383640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plastic containers and the whole-blood clotting test: glass remains the best option.
    Stone R; Seymour J; Marshall O
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1168-72. PubMed ID: 16765393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution.
    Ojito JW; Hannan RL; Burgos MM; Lim H; Huynh M; Velis E; Arocha M; Tirotta CF; Burke RP
    J Extra Corpor Technol; 2012 Mar; 44(1):15-20. PubMed ID: 22730859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.